Home > Understanding Breast Cancer > Breast Facts > Breast Facts References

  


Breast Facts References

 

  1. Rosen PP. Rosen’s Breast Pathology. Philadelphia: Lippincott Williams & Wilkins, 2001.
  2. Osborne MP and Boolbol SK. Chapter 1. Breast anatomy and development, in Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the Breast, 4th edition. Lippincott Williams and Wilkins, 2010.
  3. Smith RA, D’Orsi C, Newell MS. Chapter 11. Screening for breast cancer, in Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the Breast, 4th edition. Lippincott Williams and Wilkins, 2010.
  4. Dillon DA, Guidi AJ, Schnitt SJ. Chapter 28: Pathology of Invasive Breast Cancer, in Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the Breast, 4th edition, Lippincott Williams & Wilkins, 2010.
  5. National Cancer Institute. What you need to know about breast cancer: Symptoms. Washington, DC, National Cancer Institute, U.S. National Institutes of Health, http://www.cancer.gov/cancertopics/wyntk/breast/page5, 2009.
  6. National Cancer Institute. Paget disease of the breast. Washington, DC, National Cancer Institute, U.S. National Institutes of Health, http://www.cancer.gov/cancertopics/factsheet/sites-types/paget-breast, 2012.
  7. American Cancer Society. Signs and symptoms of breast cancer. Atlanta, GA, American Cancer Society, http://www.cancer.org/Cancer/BreastCancer/MoreInformation/BreastCancerEarlyDetection/breast-cancer-early-detection-signs-symptoms-br-ca, 2011.
  8. Centers for Disease Control and Prevention. Breast cancer: Symptoms. Atlanta, GA, Centers for Disease Control and Prevention, http://www.cdc.gov/cancer/breast/basic_info/symptoms.htm, 2011.
  9. National Comprehensive Cancer Network. NCCN Clinical practice guidelines in oncology: Breast cancer screening and diagnosis. Version 1.2012. http://www.nccn.org, 2012.
  10. National Comprehensive Cancer Network. NCCN Clinical practice guidelines in oncology: Breast cancer risk reduction. Version 1.2012. http://www.nccn.org, 2012.
  11. Vogel VG, Costantino JP, Wickerham DL, et al. for the National Surgical Adjuvant Breast and Bowel Project. Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer. Cancer Prev Res. 3(6):696-706, 2010.
  12. Rohan TE, Negassa A, Chlebowski RT, et al. Estrogen plus progestin and risk of benign proliferative breast disease. Cancer Epidemiol Biomarkers Prev. 17(9):2337-43, 2008.
  13. Rohan TE, Negassa A, Chlebowski RT, et al. Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial. J Natl Cancer Inst. 100(8):563-71, 2008.
  14. Cui Y, Page DL, Lane DS, Rohan TE. Menstrual and reproductive history, postmenopausal hormone use, and risk of benign proliferative epithelial disorders of the breast: a cohort study. Breast Cancer Res Treat. 114(1):113-20, 2009.
  15. Bertelsen L, Mellemkjaer L, Balslev E, Olsen JH. Benign breast disease among first-degree relatives of young breast cancer patients. Am J Epidemiol. 168(3):261-7, 2008.
  16. Berkey CS, Tamimi RM, Rosner B, Frazier AL, Colditz GA. Young women with family history of breast cancer and their risk factors for benign breast disease. Cancer. 118(11):2796-803, 2012.
  17. Hartmann LC, Sellers TA, Frost MH, et al. Benign breast disease and the risk of breast cancer. N Engl J Med. 353(3):229-37, 2005.
  18. Tamimi RM, Byrne B, Baer H, et al. Benign breast disease, recent alcohol consumption, and risk of breast cancer: a nested case-control study. Breast Cancer Res. 7(4):R555-62, 2005.
  19. Cui Y, Page DL, Chlebowski RT, et al. Alcohol and folate consumption and risk of benign proliferative epithelial disorders of the breast. Int J Cancer. 121(6):1346-51, 2007.
  20. Berkey CS, Willett WC, Frazier AL, et al. Prospective study of adolescent alcohol consumption and risk of benign breast disease in young women. Pediatrics. 125(5):e1081-7, 2010.
  21. Liu Y, Tamimi RM, Berkey CS, et al. Intakes of alcohol and folate during adolescence and risk of proliferative benign breast disease. Pediatrics. 129(5):e1192-8, 2012.
  22. Laronga C, Tollin S, Thurlow M. Breast cysts-diagnosis and management. In: Chagpar AB, ed. UpToDate. Waltham, MA, UpToDate, 2012.
  23. Webb PM, Byrne C, Schnitt SJ, et al. A prospective study of diet and benign breast disease. Cancer Epidemiol Biomarkers Prev. 13(7):1106-13, 2004.
  24. Sabel MS. Overview of benign breast disease. In: Chagpar AB, ed. UpToDate. Waltham, MA, UpToDate, 2012.
  25. Schnitt SJ and Collins LC. Chapter 10. Pathology of benign breast disorders, in Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the Breast, 4th edition. Lippincott Williams and Wilkins, 2010.
  26. National Cancer Institute. Understanding breast changes: a health guide for women. http://www.cancer.gov/cancertopics/screening/understanding-breast-changes.pdf, 2012.
  27. Kabat GC, Jones JG, Olson N, et al. A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer. Cancer Causes Control. 21(6):821-8, 2010.
  28. Jacobs TW, Byrne C, Colditz G, Connolly JL, Schnitt SJ. Radial scars in benign breast-biopsy specimens and the risk of breast cancer. N Engl J Med. 340(6):430-6, 1999.
  29. Santen RJ, Mansel MD. Benign breast disorders. N Engl J Med. 353(3):275-85, 2005.
  30. Sanders ME, Page DL, Simpson JF, Schuyler PA, Dale Plummer W, Dupont WD. Interdependence of radial scar and proliferative disease with respect to invasive breast carcinoma risk in patients with benign breast biopsies. Cancer. 106(7):1453-61, 2006
  31. Berg JC, Visscher DW, Vierkant RA, et al. Breast cancer risk in women with radial scars in benign breast biopsies. Breast Cancer Res Treat. 108(2):167-74, 2008.
  32. Bunting DM, Steel JR, Holgate CS, Watkins RM. Long term follow-up and risk of breast cancer after a radial scar or complex sclerosing lesion has been identified in a benign open breast biopsy. Eur J Surg Oncol. 37(8):709-13, 2011.
  33. Kudva YC, Reynolds C, O'Brien T, Powell C. Oberg AL, Crotty TB. Diabetic mastopathy, or sclerosing lymphocytic lobulitis, is strongly associated with type 1 diabetes. Diabetes Care. 25(1):121-6, 2002.
  34. Thorncroft K, Forsyth L, Desmond S, Audisio RA. The diagnosis and management of diabetic mastopathy. Breast J. 13(6):607-13, 2007.
  35. American Cancer Society. Cancer Facts and Figures 2013. Atlanta, GA: American Cancer Society, 2013.
  36. Howlader N, Noone AM, Krapcho M, et al., editors. SEER Cancer Statistics Review, 1975-2009: Fast Stats. Bethesda, MD: National Cancer Institute. http://seer.cancer.gov/csr/1975_2009_pops09/, 2012.
  37. Ravdin PM, Cronin KA, Howlander N, et al. The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med. 356(16):1670-4, 2007.
  38. Kerlikowske K, Miglioretti DL, Buist DSM, Walker R, Carney PA for the National Cancer Institute-Sponsored Breast Cancer Surveillance Consortium. Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst. 99(17):1335-9, 2007.
  39. Chlebowski RT, Kuller LH, Prentice RL, et al. for the WHI Investigators. Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med. 5;360(6):573-87, 2009.
  40. American Cancer Society. Breast Cancer Facts and Figures 2011-2012. Atlanta, GA: American Cancer Society, 2011.
  41. Forouzanfar MH, Foreman KJ, Delossantos AM, et al. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet. 378(9801):1461-84, 2011.
  42. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 127(12):2893-917, 2010.
  43. American Cancer Society. Cancer Facts and Figures for African Americans 2013-2014. Atlanta, GA: American Cancer Society, 2013.
  44. American Cancer Society. Cancer Prevention & Early Detection Facts & Figures, 2012. American Cancer Society, 2012.
  45. Centers for Disease Control and Prevention (CDC). Cancer screening - United States, 2010. MMWR Morb Mortal Wkly Rep. 61(3):41-5, 2012.
  46. National Cancer Institute. Genetics of breast and ovarian cancer (PDQ). http://www.cancer.gov/cancertopics/pdq/genetics/breast-and-ovarian/HealthProfessional, 2012.
  47. Thorlacius S, Struewing JP, Hartge P, et al. Population-based study of risk of breast cancer in carriers of BRCA2 mutation. Lancet. 352: 1337-9, 1998.
  48. Antoniou A, Pharoah PDP, Narod S, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet. 72(5):1117-30, 2003.
  49. King MC, Marks JH and Mandell JB. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science. 302: 643-6, 2003.
  50. Risch HA, McLaughlin JR, Cole DEC, et al. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst. 98(23):1694-706, 2006.
  51. John EM, Miron A, Gong G, et al. Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups. JAMA. 298 (24): 2869-76, 2007.
  52. Malone KE, Daling JR, Doody DR, et al. Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Res. 66 (16): 8297-308, 2006.
  53. Hartge P, Struewing JP, Wacholder S, Brody LC, Tucker MA. The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews. Am J Hum Genet. 64(4):963-70, 1999.
  54. Struewing JP, Abeliovich D, Peretz T, et al. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet. 11: 198-200, 1995.
  55. Oddoux C, Struewing JP, Clayton CM, et al. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nat Genet. 14: 188-90, 1996.
  56. Struewing JP, Hartge P, Wacholder S, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med. 336: 1401-8, 1997.
  57. Miller BA, Chu KC, Hankey BF, Ries LA. Cancer incidence and mortality patterns among specific Asian and Pacific Islander populations in the U.S. Cancer Causes Control. 19(3):227-56, 2008.
  58. Ziegler RG, Hoover RN, Pike MC, et al. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst. 85(22):1819-27, 1993.
  59. American Cancer Society. Cancer Facts and Figures for Hispanics/Latinos, 2012-2014. Atlanta, GA: American Cancer Society, 2013.
  60. Wingo PA, King J, Swan J, et al. Breast cancer incidence among American Indian and Alaska Native women: US, 1999-2004. Cancer. 113(5 Suppl):1191-202, 2008.
  61. Cochran SD, Mays VM, Bowen D, et al. Cancer-related risk indicators and preventive screening behaviors among lesbians and bisexual women. Am J Public Health. 91: 591-7, 2001.
  62. Case P, Austin SB, Hunter DJ, et al. Sexual orientation, health risk factors, and physical functioning in the Nurses' Health Study II. J Womens Health (Larchmt). 13(9):1033-47, 2004.
  63. Zaritsky E, Dibble SL. Risk factors for reproductive and breast cancers among older lesbians. J Womens Health (Larchmt). 19(1):125-31, 2010.
  64. Boehmer U, Miao X, Linkletter C, Clark MA. Adult health behaviors over the life course by sexual orientation. Am J Public Health. 102(2):292-300, 2012.
  65. Cochran SD, Mays VM. Risk of breast cancer mortality among women cohabiting with same sex partners: findings from the national health interview survey, 1997-2003. J Womens Health (Larchmt). 21(5):528-33, 2012.
  66. Brandenburg DL, Matthews AK, Johnson TP, Hughes TL. Breast cancer risk and screening: a comparison of lesbian and heterosexual women. Women Health. 45(4):109-30, 2007.
  67. Hart SL, Bowen DJ. Sexual orientation and intentions to obtain breast cancer screening. J Womens Health (Larchmt). 18(2):177-85, 2009.
  68. Litton JK, Theriault RL. Chapter 68. Breast cancer during pregnancy and subsequent pregnancy in breast cancer survivors, in Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the Breast, 4th edition. Lippincott Williams and Wilkins, 2010.
  69. Wisinski KB and Gradishar WJ. Chapter 64: Male Breast Cancer. In Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the Breast, 34thrd edition. Lippincott, Williams and Wilkins, 2010.
  70. National Cancer Institute. Male breast cancer treatment. http://www.cancer.gov/cancertopics/pdq/treatment/malebreast, 2012.
  71. American Society of Clinical Oncology. Breast cancer – male. http://www.cancer.net/, 2012.
  72. Mayo Clinic Staff. Male breast cancer. Mayo Clinic. http://www.mayoclinic.com/health/male-breast-cancer/DS00661, 2012.
  73. Niewoehner CB, Schorer AE. Gynaecomastia and breast cancer in men. BMJ. 336(7646):709-13, 2008.
  74. Fentiman IS, Fourquet A, Hortobagyi GN. Male breast cancer. Lancet. 367(9510):595-604, 2006.
  75. Olsson H, Bladstrom A, Alm P. Male gynecomastia and risk for malignant tumours--a cohort study. BMC Cancer. 2:26, 2002.
  76. Brinton LA, Carreon JD, Gierach GL, McGlynn KA, Gridley G. Etiologic factors for male breast cancer in the U.S. Veterans Affairs medical care system database. Breast Cancer Res Treat. 119(1):185-92, 2010.
  77. Tai YC, Domchek S, Parmigiani G, Chen S. Breast cancer risk among male BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst. 99(23):1811-4, 2007.
  78. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 61(2):69-90, 2011. 
  79. Bagaria SP, Shamonki J, Kinnaird M, Ray PS, Giuliano AE. The florid subtype of lobular carcinoma in situ: marker or precursor for invasive lobular carcinoma? Ann Surg Oncol. 18(7):1845-51, 2011.
  80. Shah-Khan MG, Geiger XJ, Reynolds C, Jakub JW, Deperi ER, Glazebrook KN. Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia/lobular carcinoma in situ) diagnosed on core needle biopsy. Ann Surg Oncol. 19(10):3131-8, 2012.
  81. Andrade VP, Ostrovnaya I, Seshan VE, et al. Clonal relatedness between lobular carcinoma in situ and synchronous malignant lesions. Breast Cancer Res. 14(4):R103, 2012.   
  82. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 62(1):10-29, 2012.

Updated 04/03/13

Related Links

Visited by Others

Komen Videos